Valdosta Teen Diagnosed With Terminal Brain Tumor

A 13-year-old resident received a diagnosis of Diffuse Intrinsic Pontine Glioma on July 13, 2026.

Updated on Oct. 10, 2026 in Cancer

Bold flat-color editorial illustration showing a solitary stone monolith pillar, evoking a sense of somber weight. — Emery Daniels of Valdosta, 13, is undergoing radiation therapy after a diagnosis of Diffuse Intrinsic Pontine Glioma, a rare pediatric brain tumor. AI Illustration. Upload story photo >

Emery Daniels of Valdosta was diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG) on July 13, 2026, after experiencing sudden symptoms including choking and stumbling. The terminal brain tumor has progressed rapidly, causing the teen to lose the ability to speak and walk.

Why it matters

DIPG is an aggressive pediatric brain tumor that currently carries a 0% survival rate. The rapid growth of the mass, which expanded by 33% in a 10-day period, necessitated an accelerated radiation treatment protocol to manage the patient's condition.

Approximately 300 children in the United States receive this diagnosis annually. The tumor carries a 0% survival rate and showed a 33% growth rate over a recent 10-day period.

The players

Emery Daniels

A 13-year-old Valdosta resident currently receiving treatment for a terminal brain tumor.

The details

Following a series of health complications, medical staff at a Jacksonville hospital confirmed the diagnosis through an MRI scan. Doctors administered an accelerated course of radiation treatment to address the significant and swift progression of the tumor.

July 2026: Symptoms such as stumbling and slurred speech appeared suddenly.
July 13, 2026: Emery Daniels was formally diagnosed with DIPG.
October 8, 2026: The patient underwent a follow-up MRI scan to assess tumor growth.

The Big Picture

This story follows a pattern set by the National Cancer Institute DIPG research protocols regarding the investigation of aggressive pediatric brain cancers.

This diagnosis highlights the critical need for families to monitor for neurological red flags such as balance issues or speech changes. Early imaging through pediatric neurology remains the primary method for identifying and managing aggressive central nervous system tumors.

The takeaway

DIPG remains a devastating diagnosis for families due to its rapid progression and current lack of viable treatment options. Medical experts emphasize the importance of specialized pediatric care when symptoms of neurological decline arise in children.